NCT07304154 2026-03-10
A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases
Gilead Sciences
Phase 1 Not yet recruiting
Gilead Sciences
Qingdao Sino-Cell Biomedicine Co., Ltd.
SCG Cell Therapy Pte. Ltd.
Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd
Letolab